A Phase 2 Proof-of-concept Study to Evaluate the Efficacy and Safety of MEDI3902 in Mechanically Ventilated Patients for the Prevention of Nosocomial Pneumonia Caused by Pseudomonas aeruginosa

Grant

Date/time Interval

  • March 12, 2018 - April 18, 2022
  • Total Award Amount

  • 74700.00
  • Direct Costs

  • 51164.00
  • Sponsor Award Id

  • 225440
  • Contributor

  • Martin Rodriguez   Investigator  
  • Peter Pappas M.D.   Investigator  
  • Todd McCarty   Principal Investigator